CERVINO
A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Near Add Your Location
Sorting 43 by
Texas Oncology
Tyler, TX
- Accepting patients
Cancer Specialists of North Florida - Southpoint
Jacksonville, FL
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
Providence St. Jude Medical Center
Fullerton, CA
- Accepting patients
American Oncology Partners of Maryland (Bethesda)
The Center for Cancer & Blood Disorders - Bethesda
Bethesda, MD
- Accepting patients
Mayo Clinic (Rochester)
Rochester, MN
- Accepting patients
Veterans Affairs Loma Linda Healthcare System
Loma Linda, CA
- Accepting patients
Beth Israel Deaconess Medical Center
Boston, MA
- Accepting patients
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA
- Accepting patients
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.